BUGWORKS is a drug discovery company that aims to discover novel pharmaceutical assets for combating Antimicrobial Resistance (AMR)

WHO WE ARE ?


A strong inter-disciplinary team with competencies in Entrepreneurship, Mathematics, Engineering, IT, Biochemistry, Microbiology, Molecular Biology, Pharmacology and Medicinal Chemistry.

 

WHAT WE DO ?


Engineering a new class of antibiotics targeting Gram Negative Bacteria

We aim to be the premier innovator of safe, effective and robust antibiotics that target Gram-negative bacteria

Our antibiotics are designed to be significantly immune to bacterial resistance and work on all known forms of drug resistant bacteria
 
 

WHY WE DO ?


  • Centers for Disease Control (CDC) estimates that 1 in 25 patients worldwide will acquire an infection as a result of their hospital stay
  • 10 million deaths will occur worldwide if antibiotic resistance is left unchecked, costing the world $100 trillion by 2050
  • The antibiotic pipeline lack new mechanisms against drug resistant Gram negative bacteria

Top News

Contact us

BUGWORKS Research India Pvt. Ltd.
Centre for Cellular & Molecular Platforms
National Centre for Biological Sciences, TIFR
GKVK Campus, Bellary Road,
Bangalore - 560065
India

Call us: +91-8296582662